Leukemia Research
Volume 29, Issue 6 , Pages 625-632 , June 2005

Therapy-related myelodysplastic syndrome in childhood: A retrospective study of 36 patients in Japan

  • M. Tsurusawa

      Affiliations

    • Department of Pediatrics, Faculty of Medicine, Aichi Medical University, Aichi 4801195, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 56162 3311; fax: +81 56162 2886.
    • ,
  • A. Manabe

      Affiliations

    • Department of Pediatrics, St Luke's International Hospital, Tokyo, Japan
    • ,
  • Y. Hayashi

      Affiliations

    • Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan
    • ,
  • Y. Akiyama

      Affiliations

    • Department of Pediatrics, Kyoto National Medical Center, Kyoto, Japan
    • ,
  • H. Kigasawa

      Affiliations

    • Division of Hematology, Kanagawa Children's Medical Center, Kanagawa, Japan
    • ,
  • H. Inada

      Affiliations

    • Department of Pediatrics, School of Medicine, Kurume University, Fukuoka, Japan
    • ,
  • Y. Noguchi

      Affiliations

    • Department of Pediatric Hematology/Oncology, Narita Red Cross Hospital, Chiba, Japan
    • ,
  • N. Sawai

      Affiliations

    • Department of Pediatrics, Komoro Kosei General Hospital, Nagano, Japan
    • ,
  • R. Kobayashi

      Affiliations

    • Department of Pediatrics, School of Medicine, Hokkaido University, Sapporo, Japan
    • ,
  • Y. Nagatoshi

      Affiliations

    • Department of Pediatrics, National Kyusyu Cancer Center, Fukuoka, Japan
    • ,
  • K. Kawakami

      Affiliations

    • Department of Pediatrics, Kagoshima City Hospital, Kagoshima, Japan
    • ,
  • S. Kojima

      Affiliations

    • Department of Pediatrics, Graduate School of Medicine, Nagoya University, Nagoya, Japan
    • ,
  • T. Nakahata

      Affiliations

    • Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • MDS committee of the Japanese Society of Pediatric Hematology

Received 15 September 2004 ,Accepted 29 November 2004.

References 

  1. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G. Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol. 1986;4:830–837
  2. Pedersen-Bjergaard J, Larsen SO, Struck J, Hansen HH, Specht L, Ersboll J, et al. Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease: relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet. 1987;330:83–88
  3. Rowley JD, Golomb HM, Vardiman JW. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981;58:759–767
  4. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes No. 5 and 7. J Clin Oncol. 1986;4:325–345
  5. Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, De Vita VT. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood. 1988;71:403–414
  6. Pui CH, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med. 1989;321:136–142
  7. Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood. 1993;82:3705–3711
  8. Andersen MK, Christiansen DH, Jensen BA, Ernst P, Hauge G, Pedersen-Bjergaard . Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature sincedkjdot. Br J Haematol. 2001;114:539
  9. Takeyama K, Seto M, Uike N, Hamajima N, Ino T, Miluni C, et al. Therapy-related leukemia and myelodysplastic symdrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. Int J Hematol. 2000;71:144–152
  10. Rowley JD, Olney HJ. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosom Cancer. 2002;33:331–345
  11. Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1993 and on 5098 unselected cases reported in the literature. Leukemia. 2002;16:2366–2378
  12. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 2003;102:43–52
  13. Tucker MA, Meadows AT, Boice JD, Stovall M, Oberlin O, Stone BJ, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst. 1987;78:459–464
  14. Pui CH, Hancock ML, Raimondi SC, Head DR, Thompson E, Wilimas J, et al. Myeloid neoplasia in children treated for solid tumours. Lancet. 1990;336:417–421
  15. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, et al. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood. 1991;78:2982–2988
  16. Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, et al. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br Med J. 1992;304:951–958
  17. Farhi DC, Obell CA, Shurin SB. Myelodysplastic syndrome and acute myeloid leukemia after treatment for solid tumors of childhood. Am J Clin Pathol. 1993;100:270–275
  18. Winick NJ, McKenna RW, Shuster JJ, Schneider NR, Borowitz MJ, Bowman WP, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol. 1993;11:209–217
  19. Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplatic syndrome in Denmark: incidence and predisposing conditions. Leukemia. 1995;9:1569–1572
  20. Bader-Meunier B, Mielot F, Tchernia G, Buisine J, Delsol G, Duchayne E, et al. Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study French Society of Paediatric Haemarology and Immunology. Br J Haematol. 1996;92:344–350
  21. Hasle H, Wadsworth L, Massing B, McBride M, Schultz K. A population-based study of childhood myelodysplastic syndrome in British Colimbia. Canada. Br J Haematol. 1999;106:1027–1032
  22. Sasaki H, Manabe A, Kojima S, Tsuchida M, Hayashi Y, Ikuta K, et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia. 2001;15:1713–1720
  23. Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol. 2003;121:758–767
  24. Le Deley MC, Leblanc T, Shamsaldin A, Raquin MA, Lacour B, Sommelet D, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the societe Francaise d’Oncologie Pediatrique. J Clin Oncol. 2003;21:1074–1081
  25. Baker KS, de For TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21:1352–1358
  26. Barnard DR, Lange B, Alonzo TA, Buckley J, Kobrinsky JN, Gold S, et al. Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation. Blood. 2002;100:427–434
  27. Leahey AM, Friedman DL, Bunin NJ. Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia. Bone Marrow Transplant. 1999;23:21–25
  28. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189–199
  29. Lawler SD, Swansbury GJ. Cytogenetic studies in primary and secondary preleukaemic states. Haematologica. 1987;72:49–53
  30. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, et al. International scording system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088
  31. Satake N, Ishida Y, Otho Y, Hinohara S, Kobayashi H, Sakakishita A, et al. Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16) (q23;p13) chromosome translocatiom. Genes Chromosom Cancer. 1997;20:60–63
  32. Nishiyama M, Arai Y, Tsunematsu Y, Kobayashi H, Asami K, Yabe M, et al. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome. Genes Chromosom Cancer. 1999;26:215–220
  33. Imamura T, Kakazu N, Hibi S, Morimoto A, Fukushima Y, Ijuin I, et al. Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8) (p23;p11). Genes Chromosom Cancer. 2003;36:413–419
  34. Kaneko M, Tsuchida Y, Mugishima H, Ohnuma N, Yamamoto K, Kawa K, et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol. 2002;24:613–621
  35. Scheres JM, Hustin TW, Geraedts CH, Leeksma CH, Meltzer PS. Translocation 1;7 in hematologic disorders:a brief review of 22 cases. Cancer Genet Cytogenet. 1985;18:207–213
  36. Gordon MY, Goldman JM. Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment. Br J Haematol. 1996;95:10–20
  37. Hasle H, Niemeier CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative disease. Leukemia. 2003;17:277–282
  38. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 2003;90:1009–1013
  39. Kumagai M, Takimoto T, Mimaya J, Eguchi H, Toyoda Y, Horibe K, et al. Childhood Hodgkin lymphoma in Japan; a survey in four Japanese childhood cancer study group. Jpn J Clin Hematol. 2003;44:146;in Japanese
  40. Breslow N, McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res. 1971;31:2098–2103
  41. Sawada T, Nagahara N, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, et al. Mass screening for neuroblastoma in Japan. Committee of the Neuroblastoma Mass Screening Study of the Japanese Society of Pediatric Oncology. Acta Paediatr Jpn. 1990;32:725–733
  42. Smith MA, Rubinstein S, Anderson L, Arthur JR, Catalano D, Freidlin PJ, et al. Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol. 1999;17:569–577
  43. Kawa K, Ohnuma N, Kaneko M, Yamamoto K, Etoh T, Mugishima H, et al. Long-term survivors of advanced neuroblastoma with mycn amplification: a report of 19 patients surviving disease-free for more than 66 Months. J Clin Oncol. 1999;17:3216–3220
  44. Hawkins MM, Stevens MCG. The long term survivors. Br Med Bull. 1996;52:898–923
  45. Hasle H. Myelodysplastic syndromes in childhood-classification,epidemiology, and treatment. Leukemia Lymphoma. 1994;13:11–26
  46. Luna-Fineman S, Shannon KM, Atwater SK, Davis J, Masterson M, Ortega J, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999;93:459–466
  47. Novitzky N, Prindull G. Myelodysplastic syndromes in children. a critical review of the clinical manifestations and management. Am J Hematol. 2000;63:212–222
  48. Bloomfield C, Archer K, Mrozek K, Lillington D, Kaneko Y, Head D, et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosom Cancer. 2002;33:362–378
  49. Taki T, Sako M, Tsuchida M, Hayashi Y. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood. 1997;89:3945–3950
  50. Albain KS, Le Beau MM, Ullirsch R, Schumacher H. Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. Genes Chromosom Cancer. 1990;2:53–58
  51. Anderson J, Gooley T, Schoch G, Anasetti C, Bensinger W, Clift R, et al. Stem cell transplantation for secondary acute myeloid leukemia: Evaluation of transplantation as initial therapy or following induction chemotherapy. Blood. 1997;89:2578–2585
  52. Manabe A, Ohtsuka Y. Third international symposium on myelodysplastic syndromes in childhood. Int J Hematol. 2003;78:475–476

PII: S0145-2126(05)00024-X

doi: 10.1016/j.leukres.2004.11.018

Leukemia Research
Volume 29, Issue 6 , Pages 625-632 , June 2005

Article Tools

* Image Usage & Resolution